<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21543">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02826421</url>
  </required_header>
  <id_info>
    <org_study_id>ILN296-P001</org_study_id>
    <nct_id>NCT02826421</nct_id>
  </id_info>
  <brief_title>Clinical Investigation of Corneal Incision Size After Intraocular Lens (IOL) Implantation</brief_title>
  <official_title>Clinical Investigation of Corneal Incision Size After IOL Implantation With Preloaded Delivery Devices and a Manual Delivery Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare corneal incision size after IOL implantation with
      the use of one of four IOL delivery systems (three preloaded IOL delivery systems and one
      manually loaded IOL delivery system).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean corneal incision size after IOL implantation (UltraSert, iTec, and iSert)</measure>
    <time_frame>Day 0, operative day</time_frame>
    <description>This endpoint is prespecified for the UltraSert, iTec, and iSert preloaded delivery systems</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean corneal incision size after IOL implantation (UltraSert and Monarch III D)</measure>
    <time_frame>Day 0, operative day</time_frame>
    <description>This endpoint is prespecified for the UltraSert preloaded delivery system and the Monarch III D delivery system</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Cataracts</condition>
  <arm_group>
    <arm_group_label>UltraSert Preloaded Delivery System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preloaded IOL delivered via a 2.2 mm clear corneal incision during cataract surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iTec Preloaded Delivery System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preloaded IOL delivered via a 2.2 mm clear corneal incision during cataract surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iSert Preloaded Delivery System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preloaded IOL delivered via a 2.2 mm clear corneal incision during cataract surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monarch III D Manual IOL Delivery System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Manually loaded IOL delivered via a 2.4 mm clear corneal incision during cataract surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UltraSert Preloaded Delivery System</intervention_name>
    <description>Includes AcrySof IQ monofocal posterior chamber IOL Model AU00T0, intended for long term use over the lifetime of the subject</description>
    <arm_group_label>UltraSert Preloaded Delivery System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iTec Preloaded Delivery System</intervention_name>
    <description>Includes TECNIS 1-piece monofocal IOL, intended for long term use over the lifetime of the subject</description>
    <arm_group_label>iTec Preloaded Delivery System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iSert Preloaded Delivery System</intervention_name>
    <description>Includes Model 251 or Model 250 posterior chamber IOL, as selected by the Investigator, intended for long term use over the lifetime of the subject</description>
    <arm_group_label>iSert Preloaded Delivery System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Monarch III D Manual IOL Delivery System</intervention_name>
    <description>Includes AcrySof IQ monofocal IOL posterior chamber IOL, intended for long term use over the lifetime of the subject</description>
    <arm_group_label>Monarch III D Manual IOL Delivery System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to comprehend and sign a statement of informed consent;

          -  Willing and able to complete all required postoperative visits;

          -  Cataract;

          -  Planned cataract removal by phacoemulsification;

          -  Calculated lens power from 18.0 through 27.0 D inclusive;

          -  Preoperative astigmatism &lt;1.0D;

          -  Other protocol-specified inclusion criteria may apply.

        Exclusion Criteria:

          -  Systemic disease that affects the cornea;

          -  Any inflammation or edema of the cornea;

          -  Previous or planned refractive or corneal surgery during the subject's participation
             in the study;

          -  Previous corneal transplant;

          -  Previous retinal detachment;

          -  Pregnancy or lactation, current or planned, during the course of the study;

          -  Current participation in another investigational drug or device study that may
             confound the results of this investigation;

          -  Any condition observed before or during surgery that in the surgeon's medical opinion
             may affect the success of the cataract surgery;

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sr. Clinical Manager, GCRA</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>March 7, 2017</lastchanged_date>
  <firstreceived_date>July 5, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intraocular lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
